General Information of the Compound
Compound ID |
CP0041761
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-(4-hydroxyphenyl)-3-({4-[2-(piperidin-1-yl)ethoxy]phenyl}carbonyl)-1-benzothiophen-6-ol
Show/Hide
|
||||||||||||||||||
Synonyms |
Raloxifene
Raloxifene (extended-release, CDT)
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C28H27NO4S
|
||||||||||||||||||
Molecular Weight |
473.594
|
||||||||||||||||||
Canonical SMILES |
Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2
Show/Hide
|
||||||||||||||||||
InChIKey |
GZUITABIAKMVPG-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
84449-90-1
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00820, Acetylcholinesterase
Protein ID: PT00905, Cytochrome P450 2C9
Protein ID: PT00886, Estrogen receptor
Cell-based Assay
Protein ID: PT00889, Estrogen receptor beta
Protein ID: PT01552, Nuclear receptor subfamily 1 group I member 2
Protein ID: PT01943, Phospholipase D1
Protein ID: PT01153, Phospholipase D2
Protein ID: PT01172, Progesterone receptor
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Clinical Information about the Compound